These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 34211481)

  • 1. Mucosal Immunization Against Pertussis: Lessons From the Past and Perspectives.
    Dubois V; Locht C
    Front Immunol; 2021; 12():701285. PubMed ID: 34211481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Mucosal Immunity in Pertussis.
    Solans L; Locht C
    Front Immunol; 2018; 9():3068. PubMed ID: 30692990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against
    Jiang W; Wang X; Su Y; Cai L; Li J; Liang J; Gu Q; Sun M; Shi L
    Front Immunol; 2022; 13():878832. PubMed ID: 35493458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
    Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C
    Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.
    Wolf MA; Boehm DT; DeJong MA; Wong TY; Sen-Kilic E; Hall JM; Blackwood CB; Weaver KL; Kelly CO; Kisamore CA; Bitzer GJ; Bevere JR; Barbier M; Damron FH
    Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33318136
    [No Abstract]   [Full Text] [Related]  

  • 6. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
    Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route.
    Li R; Lim A; Alonso S
    Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis: Where did we go wrong and what can we do about it?
    Locht C
    J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.
    Thorstensson R; Trollfors B; Al-Tawil N; Jahnmatz M; Bergström J; Ljungman M; Törner A; Wehlin L; Van Broekhoven A; Bosman F; Debrie AS; Mielcarek N; Locht C
    PLoS One; 2014; 9(1):e83449. PubMed ID: 24421886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roads to the development of improved pertussis vaccines paved by immunology.
    Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH
    Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will we have new pertussis vaccines?
    Locht C
    Vaccine; 2018 Aug; 36(36):5460-5469. PubMed ID: 29180031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Pertussis Vaccines: A Need and a Challenge.
    Hozbor D
    Adv Exp Med Biol; 2019; 1183():115-126. PubMed ID: 31432399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against
    Zurita ME; Wilk MM; Carriquiriborde F; Bartel E; Moreno G; Misiak A; Mills KHG; Hozbor D
    Front Cell Infect Microbiol; 2019; 9():125. PubMed ID: 31106160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting T
    Allen AC; Wilk MM; Misiak A; Borkner L; Murphy D; Mills KHG
    Mucosal Immunol; 2018 Nov; 11(6):1763-1776. PubMed ID: 30127384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
    Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
    Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection.
    Locht C; Papin JF; Lecher S; Debrie AS; Thalen M; Solovay K; Rubin K; Mielcarek N
    J Infect Dis; 2017 Jul; 216(1):117-124. PubMed ID: 28535276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in mice.
    Feunou PF; Kammoun H; Debrie AS; Locht C
    Vaccine; 2014 Jul; 32(34):4281-8. PubMed ID: 24950361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and evaluation of a pertactin-deficient live attenuated pertussis vaccine candidate BPZE1 derivative.
    Solans L; Debrie AS; Coutte L; Locht C
    Vaccine; 2021 May; 39(21):2843-2849. PubMed ID: 33896662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.